In this week's video, Dr. Brian Durie discusses the recently FDA approved drug ixazomib (Ninlaro®).

Bottom Line:

Ninlaro is an important addition to the lineup of myeloma treatments.

Previous Post
What should we know about FDA approval of daratumumab?
Next Post
The Black Swan Research Initiative Is the “Myeloma Moonshot”

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.